new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Co Ltd_20131212
  

Otsuka Pharmaceutical Co Ltd patents

Recent patent applications related to Otsuka Pharmaceutical Co Ltd. Otsuka Pharmaceutical Co Ltd is listed as an Agent/Assignee. Note: Otsuka Pharmaceutical Co Ltd may have other listings under different names/spellings. We're not affiliated with Otsuka Pharmaceutical Co Ltd, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "O" | Otsuka Pharmaceutical Co Ltd-related inventors




Date Otsuka Pharmaceutical Co Ltd patents (updated weekly) - BOOKMARK this page
04/13/17Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorder
03/23/17C1q-adiponectin complex and use thereof
03/16/17Piperazine-substituted benzothiophene derivatives as antipsychotic agents
03/09/17Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same
02/16/17Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
02/09/17Methods for producing aripiprazole suspension and freeze-dried formulation
01/05/17Piperazine-substituted benzothiophenes for treatment of mental disorders
11/24/16Quinolone compound
11/17/16Quantification expression level of wt1 mrna
11/17/16Device-based risk management of a therapeutic
11/10/16Emulsion composition for skin
10/27/16Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
10/27/16Pharmaceutical preparation comprising brexpiprazole and substituted beta-cyclodextrin
10/20/16Quinolone compound and pharmaceutical composition
09/01/16Drug for preventing and/or treating polycystic kidney disease
09/01/16Low hygroscopic aripiprazole drug substance and proce3sses for the preparation thereof
08/18/16Synthetic route to 2'-deoxy-2',2'-difluorotetrahydrouridines
08/11/16Cyanotriazole compounds
07/28/16Solution for oral administration
06/23/16Nanoparticles and nanoparticle composition, and producing nanoparticles and nanoparticle composition
06/09/16Tablet comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy)-1h-quinolin-2-one or a salt thereof
05/26/16Piperazine-substituted benzothiophene derivatives as antipsychotic agents
05/26/16Method of measuring insulin resistance with fatty acid combustion, and composition used herein
05/19/16Method and manufacturing nucleated tablets (as amended)
05/12/16Preventive or therapeutic agent for fibrosis
04/14/16Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer
04/14/16Aqueous ophthalmic suspension of crystalline rebamipide
03/24/16Anti-lipoarabinomannan antibody and immunoassay for acid-fast bacillary infection using the antibody
03/24/16Anti-lipoarabinomannan antibody and immunoassay for acid-fast bacillary infection using the antibody
03/03/16Heterocyclic compounds for treating or preventing disorers caused by reduced neurotransmission of serotonin, norephnephrine or dopamine
03/03/16Drug for preventing and/or treating polycystic kidney disease
02/25/16Piperazine-substituted benzothiophenes for treatment of mental disorders
02/04/16Carbostyril derivatives and mood stabilizers for treating mood disorders
01/14/16Stem cell for therapeutic use which is derived from human monocyte, and inducing same
01/07/16Suspension for oral administration comprising amorphous tolvaptan
12/31/15Cholestanol derivative for combined use
12/24/15Solid dispersion comprising amorphous cilostazol
12/10/15Injectable depot formulation comprising optically active tolvaptan and process of producing the same
12/10/15Tetomilast polymorphs
12/10/15Aptamer against midkine and applications thereof
11/19/15Method for activating helper t cell
11/19/15Medical tablet, and manufacturing method and manufacturing medical tablet
11/19/15Aripiprazole complex forumlation and method
11/12/15Primers for detecting plasmodium
10/22/15Cancer diagnostic and therapeutic method targeting molecules expressed in cancer stem cells
10/22/15Fermentation product containing equol-producing microorganism having maintained equol-producing ability, and producing same
10/01/15Prophylactic and/or therapeutic agent for behavioral and psychological symptoms associated with neurodegenerative disease or impulsive symptoms associated with mental disease containing brexpiprazole or salt thereof
10/01/15Prophylactic and/or therapeutic agent for behavioral and psychological symptoms associated with neurodegenerative disease or impulsive symptoms associated with mental disease containing brexpiprazole or salt thereof
09/10/15Iohexol powder and using the same
09/03/15Pharmaceutical composition comprising rebamipide
09/03/15Pharmaceutical composition comprising rebamipide
08/27/15Method for producing oxazole compound
08/27/15Quinolone compound
08/27/15Enzyme associated with equol synthesis
08/20/15Oral solid preparation comprising aripiprazole and producing oral solid preparation comprising aripiprazole
08/13/15Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
08/13/15Antituberculous composition comprising oxazole compounds
08/06/15Sunscreen composition
08/06/15Quinolone compound and pharmaceutical composition
07/30/15Certain compounds, compositions and methods
07/30/15Microwave heating device and firing facility
07/23/15Tablet having dry-ink film on surface thereof, and ink for inkjet printer
07/23/15Method for measuring carbohydrate metabolism ability, and composition for use in said method
07/09/15Printer and tablet
07/02/15Primers for detecting plasmodium
Patent Packs
06/25/15Printer and tablet
06/25/15Primers for detecting plasmodium
06/25/155-ht1a receptor subtype agonist
06/04/15Method for producing matrix-type pharmaceutical solid preparation
06/04/15Combination drug for treating vascular disorder
05/21/15Drug for preventing and/or treating polycystic kidney disease
05/07/15Oral formulation
04/16/154-(methylaminophenoxy)pyrdin-3-yl-benzamide derivatives for treating cancer
04/02/15Oral solid preparation comprising aripiprazole and producing oral solid preparation comprising aripiprazole
04/02/15Injectable preparation
03/26/15Sealing device and sealing method
03/26/15Injectable formulation
03/26/15Method of providing aripiprazole to patients having impaired cyp2d6 or cyp3a4 enzyme function
03/26/15Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same
03/05/15Medicinal composition for treating infarction
Patent Packs
02/19/15C1q-adiponectin complex and use thereof
02/12/15Piperazine-substituted benzothiophene derivatives as antipsychotic agents
02/05/15Sustained release oral solid preparation
01/22/15Controlled release sterile injectable aripiprazole formulation and method
01/22/15Monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same
01/15/15Oral preparation useful in measuring capacity to metabolize pyridine
01/01/15Quinolone compound
01/01/15Pharmaceutical preparation comprising brexpirazole and substituted beta-cyclodextrin
12/25/14Method for determining severity of pneumococcal pneumonia
10/23/14Enzyme associated with equol synthesis
10/23/14Quinazolines as therapeutic compounds and related methods of use
10/16/14Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
09/25/14N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
09/25/14Preventive or therapeutic agent for fibrosis
08/21/14Tablet comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1h-quinolin-2-one or a salt thereof
08/07/14Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
07/10/14Process for producing benzo [b] [1,4] diazepine-2, 4-dione compound
07/10/14Method of exhaled gas measurement and analysis and apparatus therefor
07/03/14Method of judging risk for onset of drug-induced granulocytopenia
07/03/14Method for producing benzo[b]thiophene compound
06/26/14Quinolone compound
06/12/14Piperazine-substituted benzothiophenes for treatment of mental disorders
05/29/14Drug inspection device and drug inspection method
05/01/14Drug detection device and drug detection method
05/01/14Quinolone compound and pharmaceutical composition
04/24/14Tetomilast polymorphs
04/17/14Transpulmonary liposome for controlling drug arrival
04/10/14Oxazole compound and pharmaceutical composition
03/27/14Packaging bag and producing the same
03/13/14Bioassay antibody against thyroid-stimulating hormone receptor, measurement kit for the antibody, and novel genetically modified cell for use in the bioassay method or the measurement kit
Social Network Patent Pack
03/06/14Container with concentrated substance and using the same
02/20/14Equol-producing lactic acid bacteria-containing composition
02/13/14Quinolone compound and pharmaceutical composition
02/13/14Combination drug containing probucol and a tetrazolyalkoxy-dihydrocarbostyril derivative with superoxide supressant effects
01/30/14Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
01/30/14Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders
01/30/146,7-dihydroimidazo [2,1-b] [1,3]oxazine bactericides
01/23/14Benzazepine derivatives useful as vasopressin antagonists
01/23/14Benzazepine derivatives useful as vasopressin antagonists
01/16/14Agent for improving or maintaining qol
Patent Packs
01/16/14Controlled release sterile injectable aripiprazole formulation and method
12/26/13Adiponectin for treating pulmonary disease
12/12/13Water-soluble benzoazepine compound and its pharmaceutical composition
11/14/13Medical device containing a cake composition comprising aripiprazole as an active ingredient, and a cake composition comprising aripiprazole as an active ingredient
11/07/135-ht1a receptor subtype agonist
09/19/13Proteoglycan-bonded fiber product and manufacturing same
08/22/13Composition for cleaning scalp and head hair
08/22/13Hollow confectionery and producing the same
08/22/13Pharmaceutical agent comprising quinolone compound
08/08/13N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
07/18/13Tetomilast polymorphs
06/20/13Piperazine-substituted benzothiophenes for treatment of mental disorders
06/13/13Enzyme associated with equol synthesis
05/30/13Equol-containing extract, production thereof, extraction of equol, and equol-containing food
05/23/13Benzazepine compound
04/11/13Agent for suppressing the formation of abnormal skin cells caused by exposure to light
03/21/13Epoxy compound and manufacturing the same
03/14/13Equol-containing extract, production thereof, extraction of equol, and equol-containing food
03/14/13Equol-containing extract, production thereof, extraction of equol, and equol-containing food
02/21/13Suspension and cake composition containing carbostyryl derivative and silicone oil and/or silicone oil derivative
02/14/13Benzodiazepine compound and pharmaceutical composition
01/31/13Bottled carbonated beverage containing soybean powder or soy milk
01/24/13Transcription chip
01/10/13Proteoglycan-containing microneedle array
01/03/13Processed soybean having reduced urease content and manufacturing the same
01/03/13Quinolone compound and pharmaceutical composition
12/20/12Stat3/5 activation inhibitor
12/13/12Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/13/12Quinolone compound and pharmaceutical composition
12/13/12Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Patent Packs
12/13/12Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
11/29/12Synthetic intermediate of oxazole compound and producing the same
11/01/12Equol-containing fermentation product of soybean embryonic axis, and production thereof
11/01/12Water-soluble benzoazepine compound and its pharmaceutical composition
11/01/12Water-soluble benzoazepine compound and its pharmaceutical composition
11/01/12Equol-containing fermentation product of soybean embryonic axis, and production thereof
10/11/12Therapeutic agent for chronic pain
09/20/12Aromatic compound
09/06/12Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
09/06/12Process for preparing benzazepine compounds or salts thereof
06/21/12Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and preparing the same
06/14/12Process for producing benzo[b][1,4]diazepine-2,4-dione compound
05/24/12Carbonated drink comprising soybean flour or soybean milk
05/24/121-substituted-4-nitroimidazole compound and preparing the same
04/26/12Controlled release sterile injectable aripiprazole formulation and method
04/19/125-ht1a receptor subtype agonist
04/12/125-ht1a receptor subtype agonist
03/29/12Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
03/15/12N-n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
02/02/12Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders
Social Network Patent Pack
01/19/12Cholestanol derivative for combined use
01/19/12Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
01/12/12Cholestanol derivative for combined use
01/05/12Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/01/11Method for detecting all haemophilus influenzae
12/01/115-ht1a receptor subtype agonist
11/17/115-ht1a receptor subtype agonist
11/03/11Quinolone compound and pharmaceutical composition
10/13/11Pharmaceutical agent comprising quinolone compound
08/25/11Polypeptide derived from the ryanodine receptor that inhibits calcium leakage
08/18/11Low-calorie beverage composition containing luo han guo extract and sucralose
08/18/11Method for producing recombinant virus
07/07/11Pharmaceutical solid preparation
06/23/11Method of three-dimensionally culturing chondrocytes
06/23/11Piperazine-substituted benzothiophenes for treatment of mental disorders
05/05/11Nel-related protein type 1 antibody
04/28/11Water-soluble benzoazepine compound and its pharmaceutical composition
04/07/11Water-soluble benzoazepine compound and its pharmaceutical composition
02/24/11Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof
02/17/11Use of cannabinoids in combination with an anti-psychotic medicament
Social Network Patent Pack
02/10/11Equol-containing extract, production thereof, extraction of equol, and equol-containing food
01/27/11Method for detection of pneumococcus
01/13/114-amino-5-cyanopyrimidine derivatives
12/30/10Enzyme associated with equol synthesis
12/30/10Disinfectant and/or bactericidal aqueous compositions
12/23/10Pharmaceutical solid preparation comprising benzazepines and production method thereof
12/02/10Nucleic acid complex and nucleic acid delivery composition
11/18/10Antitumor agent
11/11/10Human p51 genes and gene products thereof
10/28/10Method of judging risk for onset of drug-induced granulocytopenia
10/28/10Method of judging risk for onset of drug-induced granulocytopenia
10/28/10Method of treating cognitive impairments and schizophrenias
10/14/10Carbostyril compound
10/14/10Heterocyclic compound and pharmaceutical composition thereof
10/14/10Ly6h polypeptide
09/30/10Methods for using vasopressin antagonists with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival
08/19/10Stat3/5 activation inhibitor
08/19/10Amine salt of carbostyril derivative
08/12/10Microspheres having core/shell structure
08/05/10Metered dose inhaler
07/22/10Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor
07/01/10Epitope/peptide recognized by hla-a2402-restricted ep-cam-specific ctl and use of the same
06/24/10Fermented tea beverage and tea beverage
06/24/10Human skeletal muscle-specific ubiquitin-conjugating enzyme
05/27/10Pharmaceutical composition comprising 2,3-dihydro-6-nitroimidazo [2,1-b] oxazole derivatives
05/27/10Quinolone compound and pharmaceutical composition
05/06/10Pten inhibitor or maxi-k channels opener
04/29/10Lyophilized preparation comprising influenza vaccine, and preparation thereof
04/15/10Thiazole compound and use thereof
03/11/10Prompt nucleic acid delivery carrier composition
Social Network Patent Pack
02/25/10Human gene
12/17/09Equal-containing fermentation product of soybean embryonic axis, and production thereof
10/15/09Carrier composition for nucleic acid transport
09/03/09Oxazole compound and pharmaceutical composition
07/16/095-ht1a receptor subtype agonist
06/25/09Magnetic resonance contrast medium using polyethylene glycol and magnetic resonance image pick-up method
05/21/09Dry powder inhalation system for transpulmonary administration
04/16/09Dry powder inhalation system for transpulmonary administration
03/26/09Polynucleotide for target gene
03/26/09Process for production of 2-chloro-4-nitroimidazole
02/19/09Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol
02/19/09Gastrointestinal absorption enhancer mediated by proton-coupled transporter and its preparing method
12/12/13Water-soluble benzoazepine compound and its pharmaceutical composition







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Otsuka Pharmaceutical Co Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Otsuka Pharmaceutical Co Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';